These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7842460)

  • 41. Protection against ventricular fibrillation by the PAF antagonist, BN-50739, involves an ischaemia-selective mechanism.
    Baker KE; Curtis MJ
    J Cardiovasc Pharmacol; 1999 Sep; 34(3):394-401. PubMed ID: 10470998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of BN 52021, a specific PAF-acether antagonist, on cardiac anaphylaxis in Langendorff hearts isolated from passively sensitized guinea-pigs.
    Koltai M; Lepran I; Szekeres L; Viossat I; Chabrier E; Braquet P
    Eur J Pharmacol; 1986 Oct; 130(1-2):133-6. PubMed ID: 3780855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac ultrastructural effects of the platelet-activating factor and its antagonist BN 52021.
    Kecskeméti V; Balogh I
    Exp Toxicol Pathol; 1995 Dec; 47(6):463-70. PubMed ID: 8871085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trapped platelets activated in ischemia initiate ventricular fibrillation.
    Dhanjal TS; Medina RA; Leem J; Clark JE; Southworth R; Curtis MJ
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):995-1001. PubMed ID: 23995251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of platelet activating factor in ischaemia-reperfusion injury of isolated rabbit hearts: protective effect of a specific platelet activating factor antagonist, TCV-309.
    Katoh S; Toyama J; Kodama I; Koike A; Abe T
    Cardiovasc Res; 1993 Aug; 27(8):1430-4. PubMed ID: 8221795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of the specific PAF antagonist BN 52021 and the calcium blocker diltiazem on PAF induced arrhythmogenicity.
    Riedel A; Braquet P; Mest HJ
    Pharmacol Res Commun; 1987 Oct; 19(10):703-12. PubMed ID: 3441484
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypertrophy causes delayed conduction in human and guinea pig myocardium: accentuation during ischaemic perfusion.
    Winterton SJ; Turner MA; O'Gorman DJ; Flores NA; Sheridan DJ
    Cardiovasc Res; 1994 Jan; 28(1):47-54. PubMed ID: 8068073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion.
    Hornby EJ; Foster MR; McCabe PJ; Stratton LE
    Thromb Haemost; 1989 Jun; 61(3):429-36. PubMed ID: 2529661
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
    Baroggi N; Etienne A; Braquet P
    Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Roles of platelet-activating factor, thromboxane A2, ADP and thrombin in thrombogenesis in the guinea pig.
    Hirata Y; Takiguchi Y; Wada K; Matsuno H; Umemura K; Uematsu T; Nakashima M
    Eur J Pharmacol; 1993 Feb; 231(3):421-5. PubMed ID: 8449234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.
    Stewart AG; Dusting GJ
    Br J Pharmacol; 1988 Aug; 94(4):1225-33. PubMed ID: 2850058
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thromboxane receptor activation during bronchospasm induced by platelet-activating factor.
    Schumacher WA; Steinbacher TE
    J Lipid Mediat; 1991; 4(1):97-110. PubMed ID: 1832573
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Arrhythmias and cellular electrophysiological changes during myocardial "ischaemia" and reperfusion.
    Penny WJ; Sheridan DJ
    Cardiovasc Res; 1983 Jun; 17(6):363-72. PubMed ID: 6883412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
    László F; Whittle BJ; Moncada S
    Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Ginkgolides antagonizing some effects of platelet-activating factor in vitro].
    Dong JC; Li M; Shi ZY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Oct; 15(10):606-8. PubMed ID: 8704427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protection by cimetidine, but not ranitidine, implies that H2 receptors do not mediate arrhythmogenesis in a rat model of regional ischaemia and reperfusion in vitro.
    Banning MM; Curtis MJ
    Cardiovasc Res; 1995 Nov; 30(5):705-10. PubMed ID: 8595616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits.
    Chakrabarty S; Fluck DS; Flores NA; Sheridan DJ
    Br J Pharmacol; 1992 Nov; 107(3):705-9. PubMed ID: 1472967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
    Furci L; Fitzgerald DJ; Fitzgerald GA
    J Pharmacol Exp Ther; 1991 Jul; 258(1):74-81. PubMed ID: 1830100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.